Literature DB >> 11161369

Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms.

E Hammerlid1, C Taft.   

Abstract

To examine the health-related quality of life (HRQL) in long-term head and neck (H&amp;N) cancer survivors compared with general population norms. HRQL was assessed with three standardized questionnaires: the SF-36 Health Survey (Short Form 36) and the EORTC QLQ-C30 and QLQ-H&amp;N35 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, -Core 30 and -Head and Neck 35 cancer module). Altogether 135 H&amp;N cancer patients (mean age 62 years, 31% females) of 151 survivors (89% acceptance) from a longitudinal HRQL study (n = 232) were included 3 years after diagnosis. The H&amp;N cancer patients' SF-36 scores did not differ significantly from those of an age- and sex-matched sample (n = 871) from the Swedish normative population, except on the role-physical functioning scale. On the other hand, treatment-related side-effects and disease-specific problems (e.g., swallowing, local pain and dry mouth) measured by the H&amp;N cancer module were, with few exceptions, significantly worse than norm values. Gender comparisons revealed that female H&amp;N cancer patients generally scored better than the norms on both the SF-36 and the EORTC QLQ-C30, while the male patients scored significantly worse on most SF-36 scales. Patients > or =65 years more often scored worse than the norm than did patients <65. Clinically relevant differences were found on the majority of SF-36 scales in comparison of tumour sites, however, comparisons of patients with small (stage I+II) versus advanced (stage III+IV) tumours revealed few differences. Three years after diagnosis H&amp;N cancer patients still suffer significant functional limitations/problems related to their disease and its treatment but these problems do not generally affect their overall HRQL. Tumour stage no longer differentiates HRQL at 3 years, however, factors related to the patients' age, gender and location of the tumour appear to have bearing on their reported health status. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2001        PMID: 11161369      PMCID: PMC2363699          DOI: 10.1054/bjoc.2000.1576

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden.

Authors:  M Sullivan; J Karlsson; J E Ware
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

3.  Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.

Authors:  K Bjordal; S Kaasa
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

Review 4.  Psychosocial aspects of head and neck cancer--a review of the literature.

Authors:  J F Pruyn; P C de Jong; L J Bosman; J W van Poppel; H W van Den Borne; R M Ryckman; K de Meij
Journal:  Clin Otolaryngol Allied Sci       Date:  1986-12

5.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

6.  Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

Authors:  D Osoba; B Zee; J Pater; D Warr; L Kaizer; J Latreille
Journal:  Qual Life Res       Date:  1994-10       Impact factor: 4.147

7.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

8.  Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy.

Authors:  K Bjordal; S Kaasa; A Mastekaasa
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-03-01       Impact factor: 7.038

9.  Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study.

Authors:  K Bjordal; A Freng; J Thorvik; S Kaasa
Journal:  Eur J Cancer B Oral Oncol       Date:  1995-07

10.  Psychological distress in head and neck cancer patients 7-11 years after curative treatment.

Authors:  K Bjordal; S Kaasa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  65 in total

Review 1.  Advances in quality of life research among head and neck cancer patients.

Authors:  Allen C Sherman; Stephanie Simonton
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

2.  A split-parotid delineation approach for dose optimization in volumetric modulated arc therapy for nasopharyngeal carcinoma patients with parapharyngeal space invasion and level IIa cervical lymph node involvements.

Authors:  Wei Xiao; Zhixiong Lin; Wuzhe Zhang; Mei Li; Vincent W C Wu
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

3.  Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  H B Zhang; X Lu; S M Huang; L Wang; C Zhao; W X Xia; S W Li; F L Wang; Y L Zhu; X Guo; Y Q Xiang
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

4.  Managing Health Care After Cancer Treatment: A Wellness Plan.

Authors:  Jennifer Moye; Maura Langdon; Janice M Jones; David Haggstrom; Aanand D Naik
Journal:  Fed Pract       Date:  2014-05-01

5.  Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.

Authors:  Sarah Nicole Hamilton; Omair Arshad; Jaime Kwok; Eric Tran; A Fuchsia Howard; Isabel Serrano; Karen Goddard
Journal:  Support Care Cancer       Date:  2018-11-22       Impact factor: 3.603

6.  Implementing Yoga Therapy Adapted for Older Veterans Who Are Cancer Survivors.

Authors:  Katherine King; Jeffrey Gosian; Kelly Doherty; Jnani Chapman; Christina Walsh; Jill Pokaski Azar; Suzanne C Danhauer; Jennifer Moye
Journal:  Int J Yoga Therap       Date:  2014

7.  Quality of life related to swallowing after tongue cancer treatment.

Authors:  Anna Karinne Costa Bandeira; Elma H M Azevedo; José Guilherme Vartanian; Inês N Nishimoto; Luiz Paulo Kowalski; Elisabete Carrara-de Angelis
Journal:  Dysphagia       Date:  2007-11-13       Impact factor: 3.438

8.  Self-perception versus professional assessment of functional outcome after ablative surgery in patients with oral cancer.

Authors:  Benedicta E Beck-Broichsitter; Jörn Huck; Thomas Küchler; Daniela Hauke; Jürgen Hedderich; Jörg Wiltfang; Stephan T Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-18       Impact factor: 4.553

Review 9.  Cancer survivorship and aging : moving the science forward.

Authors:  Keith M Bellizzi; Karen M Mustian; Oxana G Palesh; Michael Diefenbach
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

10.  Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.

Authors:  Joel B Epstein; Diana J Wilkie; Dena J Fischer; Young-Ok Kim; Dana Villines
Journal:  Head Neck Oncol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.